With an initial investment of INR 3.3 million, Natco Pharma Ltd was established in Hyderabad in 1981. Natco started as a small business with just one unit and 20 people. Now, Natco has eight manufacturing sites across India with contemporary research labs, the ability to develop new drugs, etc. Now employing about 4500 people, Natco Family is one of India's pharmaceutical enterprises with the quickest growth rates. Natco is highly known for its creativity in pharmaceutical research and development. A pharmaceutical firm with a strong focus on R&D, Natco Pharma Ltd develops, produces, and markets final dosage formulations (FDF) and active pharmaceutical ingredients (APIs). Our main areas of concentration are sophisticated items and specialized therapeutic areas. Our products are marketed and sold in more than 40 nations. We market and sell our FDF goods throughout the world, including in the US, India, Europe, and RoW. With our companies, we also operate in several important geographic areas. We produce API goods that are mainly consumed captively in our FDF products and are also marketed to customers for a variety of overseas markets, including Brazil, Europe, and the USA. We can create and produce products using multi-step synthesis, semi-synthetic, and APIs.